HK1040196A1 - Low dose entecavir formulation and use - Google Patents
Low dose entecavir formulation and useInfo
- Publication number
- HK1040196A1 HK1040196A1 HK02101639.3A HK02101639A HK1040196A1 HK 1040196 A1 HK1040196 A1 HK 1040196A1 HK 02101639 A HK02101639 A HK 02101639A HK 1040196 A1 HK1040196 A1 HK 1040196A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- low dose
- dose entecavir
- entecavir formulation
- formulation
- low
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18567200P | 2000-02-29 | 2000-02-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1040196A1 true HK1040196A1 (en) | 2002-05-31 |
Family
ID=22681972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02101639.3A HK1040196A1 (en) | 2000-02-29 | 2002-03-04 | Low dose entecavir formulation and use |
Country Status (4)
Country | Link |
---|---|
CN (5) | CN101385732A (en) |
HK (1) | HK1040196A1 (en) |
UY (1) | UY26595A1 (en) |
ZA (1) | ZA200205900B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1732944B (en) * | 2005-09-02 | 2013-05-08 | 海南中和药业有限公司 | Entecavir dispersible tablet and its preparation process |
CN1820744B (en) * | 2006-04-04 | 2011-01-26 | 中国人民解放军军事医学科学院毒物药物研究所 | Oseltamivir phosphate granula and its preparing method |
CN101244260B (en) * | 2007-02-14 | 2011-12-28 | 成都地奥九泓制药厂 | Combined medicament for treating chronic hepatitis B |
CN101371841A (en) * | 2007-08-23 | 2009-02-25 | 浙江医药股份有限公司新昌制药厂 | Crystallization type Entecavir formulation as well as preparation method and use thereof |
CN102578564A (en) * | 2011-11-01 | 2012-07-18 | 江苏江山制药有限公司 | Preparation method for rapid-disintegrating directly-pressed particle mannitol preparation |
CN102416003A (en) * | 2011-12-08 | 2012-04-18 | 南京优科生物医药有限公司 | Method for preparing entecavir tablets |
CN102552210B (en) * | 2012-01-10 | 2013-12-11 | 四川海思科制药有限公司 | Entecavir capsule and preparation method thereof |
KR101285008B1 (en) * | 2012-04-18 | 2013-07-10 | 제일약품주식회사 | A method for preparing oral formulation of low dose entecavir |
TW202337477A (en) * | 2015-02-01 | 2023-10-01 | 美商錫羅斯製藥公司 | High surface-area lyophilized compositions comprising arsenic for oral administration in patients |
CN112535736B (en) * | 2020-12-14 | 2023-08-29 | 石家庄四药有限公司 | Entecavir composition and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4489026A (en) * | 1982-09-07 | 1984-12-18 | The Upjohn Company | Process for preparing solid unit dosage forms of ultra-low dose drugs |
US5206244A (en) * | 1990-10-18 | 1993-04-27 | E. R. Squibb & Sons, Inc. | Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines |
PH30929A (en) * | 1992-09-03 | 1997-12-23 | Janssen Pharmaceutica Nv | Beads having a core coated with an antifungal and a polymer. |
-
2000
- 2000-08-29 CN CNA2008101492879A patent/CN101385732A/en active Pending
- 2000-08-29 CN CN 00126403 patent/CN1310999A/en active Pending
- 2000-08-29 CN CN 200510128719 patent/CN1813753B/en not_active Ceased
- 2000-08-29 CN CN2012101468842A patent/CN102772413A/en active Pending
- 2000-08-29 CN CN 200810170016 patent/CN101444511B/en not_active Expired - Lifetime
-
2001
- 2001-02-23 UY UY26595A patent/UY26595A1/en not_active IP Right Cessation
-
2002
- 2002-03-04 HK HK02101639.3A patent/HK1040196A1/en unknown
- 2002-07-23 ZA ZA200205900A patent/ZA200205900B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1813753B (en) | 2010-04-07 |
CN102772413A (en) | 2012-11-14 |
CN1813753C (en) | |
ZA200205900B (en) | 2004-03-29 |
CN1310999A (en) | 2001-09-05 |
CN101444511A (en) | 2009-06-03 |
UY26595A1 (en) | 2001-09-28 |
CN101385732A (en) | 2009-03-18 |
CN1813753A (en) | 2006-08-09 |
CN101444511B (en) | 2013-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG24408A (en) | Low dose entecavir formulation and use | |
IL141034A0 (en) | Uracil compounds and use thereof | |
HK1061037A1 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
PT1296974E (en) | 2-cyanopyrrolidine derivatives and their use as medicaments | |
EP1367060A4 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof | |
EP1364957A4 (en) | Glycopyranosyloxypyrazole derivatives and medicinal use thereof | |
EP1364958A4 (en) | Glycopyranosyloxypyrazole derivatives and medicinal use thereof | |
HK1068555A1 (en) | New formulations and use thereof | |
IL185461A0 (en) | Pyrimidine compounds and their use | |
GB0101035D0 (en) | Formulation and use thereof | |
PL372322A1 (en) | Low dose liquid entecavir formulations and use | |
IL139899A (en) | Uracil compounds and use thereof | |
HK1040196A1 (en) | Low dose entecavir formulation and use | |
PL363048A1 (en) | Azabicyclic derivatives and their therapeutic use | |
GB0007530D0 (en) | Trityl-type compounds and their use | |
GB0021497D0 (en) | Compounds and their use | |
GB0018887D0 (en) | Compound and their therapeutic use | |
GB0023473D0 (en) | Therapeutic use and formulation | |
AU5104101A (en) | Composition and use | |
GB9926528D0 (en) | Therapeutic use and formulation | |
GB0021927D0 (en) | Use of pharmaceutical combination | |
GB0018888D0 (en) | Compounds and their therapeutic use | |
GB0018886D0 (en) | Compounds and their therapeutic use | |
GB0018885D0 (en) | Compounds and their therapeutic use | |
GB0014191D0 (en) | Use and combined preparation |